AIMAH
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study of Efficacy and Safety of Osilodrostat in Cushing's Syndrome (NCT02468193) | Novartis Pharmaceuticals | 2015-09-24 |
Track AIMAH automatically
Every clearance here is in the API, with alerts when new ones post.